Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
复制标题
DOI：
10.7326/0003-4819-149-9-200811040-00243
复制
发表时间：
2008-11-04
影响因子：
39.2
通讯作者：
Yawn, Barbara P.
中科院分区：
文献类型：
--
作者：
Calonge, Ned;Petitti, Diana B.;Yawn, Barbara P.
描述：2002年美国的更新。S.预防服务工作组（USPSTF）关于结直肠癌筛查的建议声明。方法：为了更新其建议，USPSTF委托进行了2项研究：1）对与筛查技术的测试特征和益处和危害相关的4个选定问题进行有针对性的系统证据审查，和2）决策分析建模分析，使用人口建模技术比较可用筛查方式的预期健康结果和资源需求建议：USPSTF建议在成人中使用粪便潜血试验、乙状结肠镜检查或结肠镜检查筛查结直肠癌，从50岁开始，一直持续到75岁。这些筛查方法的风险和益处各不相同。USPSTF建议不要对76至85岁的成年人进行结肠直肠癌的常规筛查。可能有一些考虑因素支持个体患者的结直肠癌筛查。（C建议）USPSTF建议对85岁以上的成年人进行结肠直肠癌筛查。（D建议）USPSTF的结论是，证据不足以评估计算机断层结肠成像和粪便DNA检测作为结直肠癌筛查方式的益处和危害。（一声明）
Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer.Methods: To update its recommendation, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review on 4 selected questions relating to test characteristics and benefits and harms of screening technologies, and 2) a decision analytic modeling analysis using population modeling techniques to compare the expected health outcomes and resource requirements of available screening modalities when used in a programmatic way over time.Recommendations: The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary. (A recommendation)The USPSTF recommends against routine screening for colorectal cancer in adults 76 to 85 years of age. There may be considerations that support colorectal cancer screening in an individual patient. (C recommendation)The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years. (D recommendation)The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement)